Saturday, November 28, 2015

Report: Pfizer might sell infant-nutrition unit to Nestle

Pfizer reportedly has a deal to sell its infant-nutrition division to Nestle for $9 billion.

Report: Pfizer might sell infant-nutrition unit to Nestle


Pfizer said last July that it might sell its infant nutrition and animal health divisions and the Wall Street Journal reported that Pfizer is close to a $9 billion deal with Nestle on the infant food group.

If it pans out, Nestle will have outbid a group off from Groupe Danone SA, the yogurt makers, and Mead Johnson Nutrition Co.

The link to the Journal story is here.

Inquirer Staff Writer
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at or 215-854-4506.

David Sell Inquirer Staff Writer
Also on
letter icon Newsletter